Acima Private Wealth’s Alexion Pharmaceuticals ALXN Stock Holding History

Acima Private Wealth’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-37	Closed	-$7K	–	237
2021 Q2	$7K	Hold	37	–	–	﹤0.01%	213
2021 Q1	$6K	Hold	37	–	–	﹤0.01%	214
2020 Q4	$6K	Sell	37 -31	-46%	-$3.98K	﹤0.01%	216
2020 Q3	$8K	Hold	68	–	–	﹤0.01%	198
2020 Q2	$8K	Hold	68	–	–	0.01%	217
2020 Q1	$6K	Hold	68	–	–	﹤0.01%	235
2019 Q4	$7K	Hold	68	–	–	﹤0.01%	250
2019 Q3	$6K	Hold	68	–	–	﹤0.01%	241
2019 Q2	$9K	Hold	68	–	–	0.01%	211
2019 Q1	$9K	Sell	68 -6	-8%	-$746	0.01%	211
2018 Q4	$7K	Buy	+74	New	+$8.75K	0.01%	221

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Acima Private Wealth's ALXN Position: Q3 2021 in Review

Acima Private Wealth sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 37 shares — an estimated $7K sold.

Acima Private Wealth first reported a position in ALXN in Q4 2018 and held it in 11 quarters. The position peaked at $9K in Q2 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Acima Private Wealth reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Acima Private Wealth sold 37 Alexion Pharmaceuticals shares in Q3 2021, an estimated $7K.
Acima Private Wealth first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 11 quarters.
Acima Private Wealth's Alexion Pharmaceuticals position peaked at $9K in Q2 2019.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Acima Private Wealth's 13F filing for Q3 2021, filed 9 Nov 2021.